Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

93.16 +0.23 (+0.25%)
Streaming Delayed Price Updated: 3:45 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,867,865
Open 93.23
Bid (Size) 93.15 (400)
Ask (Size) 93.16 (1,000)
Prev. Close 92.92
Today's Range 92.67 - 94.75
52wk Range 73.31 - 105.07
Shares Outstanding 2,531,374,696
Dividend Yield 3.48%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation. 
Via Benzinga
Topics ETFs
News headline image
Market Grapples with Valuation Fears Amidst Accelerating Sector Rotation
As November 2025 unfolds, the global financial markets find themselves at a critical juncture, characterized by a palpable sense of unease over elevated valuations in specific sectors and a pronounced... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy

Performance

YTD
-6.1%
-6.1%
1 Month
+9.9%
+9.9%
3 Month
+10.6%
+10.6%
6 Month
+20.6%
+20.6%
1 Year
-3.5%
-3.5%

More News

Read More
Cidara Therapeutics Stock Rockets Over 700% This Year — Then Wall Street Turns Neutral On Merck Takeover ↗
Via Stocktwits
News headline image
Top 2 Health Care Stocks That May Fall Off A Cliff This Month ↗
Via Benzinga
News headline image
MERCK & CO. INC. (NYSE:MRK): A Value Investment with Strong Fundamentals ↗
Via Chartmill
News headline image
These 2 Dividend ETFs Are a Retiree's Best Friend ↗
Via The Motley Fool
Topics Artificial Intelligence Bonds ETFs
News headline image
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
Via TokenRing AI
Topics Artificial Intelligence Economy Product Recall
News headline image
AI and Digital Twins Ignite a New Era of Accelerated Drug Discovery and Development
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal ↗
Via Investor's Business Daily
News headline image
Merck Makes Big Bet On Flu Protection With Cidara Buyout ↗
Via Benzinga
News headline image
Merck To Buy Cidara In $9.2B Deal To Strengthen Antiviral Portfolio ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
From Merck & Co., Inc.
Via Business Wire
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗
Via Stocktwits
News headline image
Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Merck to Participate in the Jefferies Global Healthcare Conference in London
From Merck & Co., Inc.
Via Business Wire
News headline image
Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors? ↗
Via The Motley Fool
Topics ETFs Economy Retirement
News headline image
The Data Drought of 2024: Recalling the Urgent Call for November Jobs and CPI Figures Post-Shutdown
Via MarketMinute
Topics Economy
News headline image
Nasdaq Stumbles: Tech Sector Faces Reality Check Amid Valuation Concerns and Sector Rotation
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Dow Jones Soars to Unprecedented Heights as Market Cheers Government Shutdown Resolution
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Unprecedented Market Anomaly: Gold and Silver Soar as Dow Breaches 48,000 Amidst Inflationary Fears and Geopolitical Tensions
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Dow Soars Past 48,000 as Gold and Silver Shine in a Market of Paradox
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Dow Breaches 48,000 Milestone Amidst Government Shutdown Resolution Hopes, S&P 500 and Nasdaq Lag
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
2 Strong Healthcare Stock Picks for Value Investors ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 93.16
When was Merck & Co last traded?
The last trade of Merck & Co was at 11/17/25 03:45 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 235.81B
How many shares of Merck & Co are outstanding?
Merck & Co has 236B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.